PsA (n=10 525) | GPC (n=20 777) | |
---|---|---|
Female, no. (%) | 6222 (59.1) | 12 311 (59.3) |
Age, no. (%) | ||
<20 | 201 (1.9) | 403 (1.9) |
20–29 | 715 (6.8) | 1414 (6.8) |
30–39 | 1707 (16.2) | 3392 (16.3) |
40–49 | 2431 (23.1) | 4831 (23.3) |
50–59 | 2812 (26.7) | 5572 (26.8) |
60–69 | 1686 (16.0) | 3298 (15.9) |
70–79 | 765 (7.3) | 1472 (7.1) |
>80 | 208 (2.0) | 395 (1.9) |
Married/coliving, no. (%) | 7320 (69.5) | 14 395 (69.3) |
Comorbidities | PsA (n=7508*) | GPC (n=14 800*) |
Infections, no. (%) | 251 (3.3) | 249 (1.7) |
Neoplasms, no. (%) | 502 (6.7) | 805 (5.4) |
Haematological disorders, no. (%) | 156 (2.1) | 161 (1.1) |
Endocrine and metabolic disorders, no. (%) | 658 (8.8) | 816 (5.5) |
Mental disorders, no. (%) | 220 (2.9) | 379 (2.6) |
Nervous system, no. (%) | 489 (6.5) | 502 (3.4) |
Cardiovascular disorders, no. (%) | 1060 (14.1) | 1340 (9.1) |
Respiratory disorders, no. (%) | 522 (7.0) | 613 (4.1) |
Digestive tract disorders, no. (%) | 965 (12.9) | 1075 (7.3) |
Skin disorders, no. (%) | 778 (10.4) | 335 (2.3) |
Musculoskeletal system, no. (%) | 2884 (38.4) | 1936 (13.1) |
Genitourinary disorders, no. (%) | 796 (10.6) | 1210 (8.2) |
*Please note that comorbidities required at least 3 years of observation prior and after inclusion date.
GPC, general population comparator; PsA, psoriatic arthritis.